| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
GNI Group Ltd (OTCGREY: GNIIF)
GNIIF Technical Analysis
5
| As on 1st Jan 2026 GNIIF STOCK Price closed @ 15.50 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.13 & Strong Sell for SHORT-TERM with Stoploss of 0.57 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GNIIFSTOCK Price
| Open | 15.50 | Change | Price | % |
| High | 15.50 | 1 Day | -0.45 | -2.82 |
| Low | 15.50 | 1 Week | -0.45 | -2.82 |
| Close | 15.50 | 1 Month | -0.45 | -2.82 |
| Volume | 100 | 1 Year | -0.45 | -2.82 |
| 52 Week High 15.95 | 52 Week Low 15.50 | ||||
OTCGREY USA Most Active Stocks
| XANAF | 0.04 | -33.33% |
| IARED | 24.62 | % |
| CVMCA | 22.54 | -0.75% |
| JRVMF | 0.01 | 0.00% |
| GCEA | 29.00 | -21.20% |
| AHLD | 82.75 | -2.93% |
| MAXC | 1.78 | 0.00% |
| KAKZF | 110.12 | 4.72% |
| MNSLV | 25.50 | 1.03% |
| ABSOF | 0.03 | -62.50% |
OTCGREY USA Top Gainers Stocks
OTCGREY USA Top Losers Stocks
| GNIIF Daily Charts |
GNIIF Intraday Charts |
Whats New @ Bazaartrend |
GNIIF Free Analysis |
|
|
GNIIF Important Levels Intraday
| RESISTANCE | 15.50 |
| RESISTANCE | 15.50 |
| RESISTANCE | 15.50 |
| RESISTANCE | 15.50 |
| RESISTANCE | 15.50 |
| RESISTANCE | 15.50 |
| RESISTANCE | 15.50 |
| RESISTANCE | 15.50 |
GNIIF Forecast March 2026
| 4th UP Forecast | 16.37 |
| 3rd UP Forecast | 16.09 |
| 2nd UP Forecast | 15.92 |
| 1st UP Forecast | 15.75 |
| 1st DOWN Forecast | 15.25 |
| 2nd DOWN Forecast | 15.08 |
| 3rd DOWN Forecast | 14.91 |
| 4th DOWN Forecast | 14.63 |
GNIIF Weekly Forecast
| 4th UP Forecast | 16.37 |
| 3rd UP Forecast | 16.09 |
| 2nd UP Forecast | 15.92 |
| 1st UP Forecast | 15.75 |
| 1st DOWN Forecast | 15.25 |
| 2nd DOWN Forecast | 15.08 |
| 3rd DOWN Forecast | 14.91 |
| 4th DOWN Forecast | 14.63 |
GNIIF Forecast2026
| 4th UP Forecast | 16.37 |
| 3rd UP Forecast | 16.09 |
| 2nd UP Forecast | 15.92 |
| 1st UP Forecast | 15.75 |
| 1st DOWN Forecast | 15.25 |
| 2nd DOWN Forecast | 15.08 |
| 3rd DOWN Forecast | 14.91 |
| 4th DOWN Forecast | 14.63 |
GNI Group Ltd ( OTCGREY USA Symbol : GNIIF )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
GNIIF Other Details
| Segment | EQ | |
| Market Capital | 130171280.00 | |
| Sector | Other | |
| Industry | Other | |
| Offical website | > echo $website ; ?> | |
GNIIF Address
![]() |
||
GNIIF Latest News
GNIIF Business Profile
GNI Group Ltd. researches, develops, manufactures, and sells pharmaceutical drugs and traditional Chinese medicines in Japan and internationally. The company provides Etuary for the treatment of idiopathic pulmonary fibrosis. It is also developing Etuary for the treatment of radiation pneumonitis, which is in pilot study for Phase III clinical trials; Tamibarotene, a product for treating acute promyelocytic leukemia; and F351 that is in Phase II clinical trial for the treatment of liver fibrosis. In addition, the company is developing Etuary for the treatment of diabetic nephropathy and connective tissue disease associated interstitial lung disease; and F573 for acute liver failure and acute-on-chronic liver failure. Further, it is developing diabetic nephropathy; and connective tissue disease associated interstitial lung disease, which are in investigational new drug application stage. GNI Group Ltd. was founded in 2001 and is headquartered in Tokyo, Japan. Address: Nihonbashi-Honcho YS Building, Tokyo, Japan, 103-0023
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

